IP Verse

Crenolanib For Treating Flt3 Mutated Proliferative Disorders - EP2941251

PATENT ANALYSIS

Patent Details

Grant Date: Mar 7, 2018
Company: AROG PHARMACEUTICALS, INC.
Oppositions

More patents of Arog Pharmaceuticals, Inc.

Want to monitor this patent?

Feel free to send us a message here and we will get back to you